WeOxy steps into HME channel, taps industry vet to lead sales
By HME News Staff
Updated 1:52 PM CDT, Thu May 28, 2026
CAMBRIDGE, Mass. – WeOxy has soft launched the WeOxy Q5, its next-gen portable oxygen concentrator (POC), and appointed industry veteran John Stelzner as vice president of sales. The company is offering qualified DME providers the opportunity to request a WeOxy Q5 at no cost to evaluate with their own patients.
About John Stelzner
Stelzner brings decades of respiratory and HME industry experience, including as vice president of sales, Eastern U.S., at Philips Respironics; vice president of sales and business development at Philips; and vice president of sales at ABM Respiratory Care, where he led the company to market leadership in cough stimulation.
“WeOxy has built something genuinely different — clinically superior, operationally better for providers, and designed in a way patients will actually embrace,” he said. “After 40 years in this industry, I know how rare that combination is.”
About WeOxy Q5
The Q5 offers an extended battery life with fast charging speeds using a universal USB-C platform. Additional features include a three-year sieve bed warranty, a five-year overall device warranty, and a direct strap-mount design intended to reduce drop risk and eliminate the need for carrying bags. WeOxy operates on a replacement-first policy and will ship a new unit the same day if there is a problem.
Comments